Most Recent
‘Inherently implausible’: Generic Partners loses fight with Neurim over melatonin drug patent
Intellectual Property 2022-01-20 2:59 pm By Cindy Cameronne

Israeli drug company Neurim Pharmaceuticals has won an eight month extension to apply for a grace period for its melatonin tablet patent to treat children with autism spectrum disorder after Australian company Generic Partners lost its “inherently implausible” opposition to the patent.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Repipe loses appeal in battle with IP Australia over computer-implemented invention
Intellectual Property 2021-12-10 11:39 am By Cindy Cameronne

The Full Federal Court has shot down plumbing company Repipe’s appeal of a decision rejecting its innovation patents for a claimed computer-implemented invention, saying it only addressed issues in business operations rather than improving on computer technology.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Full Court parks opposition to patent for detecting parking overstays
Appeals 2021-12-09 12:01 pm By Miklos Bolza

Tech company Vehicle Management Systems has come up short in its third attempt to block competitor SARB Management Group’s patent application for a magnetic parking overstay detector, with the Full Court rejecting claims that VMS’ managing director should have been listed as the device’s inventor.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

a2 Milk wins trade mark ruling after IP Australia left ‘legitimate uncertainty’
Intellectual Property 2021-12-03 5:08 pm By Miklos Bolza

A judge has allowed two a2 Milk trade marks to proceed to registration despite “legitimate uncertainty” created by IP Australia in a long-running intellectual property spat with competitor Lion Dairy & Drinks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ono Pharmaceutical faces grilling by Full Court in patent extension appeal
Intellectual Property 2021-11-04 9:20 pm By Miklos Bolza

Drug company Ono Pharmaceutical has faced tough questioning by an appeals court in a fight with IP Australia over a decision that secured it a patent extension for its cancer immunotherapy drug Opdivo.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Latest patent ruling rejecting AI inventorship puts Federal Court in minority
Intellectual Property 2021-09-24 1:58 pm By Miklos Bolza

The Federal Court’s decision that artificial intelligence can be listed on a patent application as the inventor has become an outlier, as the UK joins the US in rejecting what has become an international battle to claim AI inventorship.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Canva gets more time to patent website invention after lawyer mess-up
Intellectual Property 2021-09-20 12:06 pm By Miklos Bolza

Graphics design platform Canva has been conditionally granted further time to apply to patent an invention for generating websites, after IP Australia found its US patent attorneys had made an “error or omission” by failing to track expiration dates for registering the patent.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme appeals judgment tossing Januvia patent extension
Intellectual Property 2021-09-10 6:04 pm By Miklos Bolza

Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Cytec prevails again in challenge to Nalco mining patent
Energy & Natural Resources 2021-08-19 3:34 pm By Miklos Bolza

US-based chemical and materials technology company Cytec Industries has won its Federal Court challenge to a mining patent application by a unit of Ecolab, with the court finding the claims in the patent lacked support and sufficient disclosure.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court throws out Merck Sharp & Dohme’s Januvia patent extension
Intellectual Property 2021-08-12 2:29 pm By Miklos Bolza

The Federal Court has dealt US drug giant Merck Sharp & Dohme a devastating blow, overturning an “untenable” patent term extension which would have protected the monopoly of its multibillion-dollar Januvia and Janumet diabetes drugs beyond July 2o22.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?